"10.1371_journal.pone.0049006","plos one","2012-11-13T00:00:00Z","Mary P McGowan; Jean-Claude Tardif; Richard Ceska; Lesley J Burgess; Handrean Soran; Ioanna Gouni-Berthold; Gilbert Wagener; Scott Chasan-Taber","Cardiometabolic Risk Reduction and Research Center of New England, Bedford, New Hampshire, United States of America; Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada; Centre for Preventive Cardiology, General Teaching Hospital and First Medical Faculty of Charles University in Prague, Prague, Czech Republic; Cardiology Unit, Stellenbosch University and Tygerberg Hospital, Parow, South Africa; University Department of Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom; Center of Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany; Clinical Research, Genzyme Corporation, Almere Stad Area, The Netherlands; Biostatistics, Genzyme Corporation, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: MPM GW. Performed the experiments: MPM JCT RC LJB HS IGB. Analyzed the data: MPM JCT RC LJB HS IGB GW SCT. Contributed reagents/materials/analysis tools: MPM JCT RC LJB HS IGB SCT. Wrote the paper: MPM JCT RC LJB HS IGB.","MPM has consulted for and participated in two Genzyme Advisory Board Meetings. She is currently an employee of Genzyme; however, this manuscript was completed prior to this employment. MPM was the lead investigator and developed the manuscript. She has served on the following speakers bureaus: Glaxo Smith Kline and Merck-Schering Plough. JCT acknowledges grants from Genzyme to his institution. RC is an advisory board member for: Genzyme, KOWA, and MSD; and is a speaker for Abbott, ASTRA-ZENECA, MSD, Pfizer, and Sanofi. LJB reports no conflicts. HS received fees for lectures and consultancy work from Genzyme as well as research grants from MSD Sharp & Dohme and Pfizer. IGB received payments for lectures and speakers bureaus from MSD Sharp & Dohme and Genzyme. She has received travel expenses and meeting expenses from Otsuka and Novartis as well as a grant for research from Bayer Healthcare. GW and is an employee of Genzyme, a Sanofi Company. SCT is a past employee of Genzyme. This does not alter the authors’ adherence to all PLOS One policies on sharing data and materials.","2012","11","Mary P McGowan","MPMG",8,TRUE,2,6,8,6,TRUE,TRUE,FALSE,0,NA,FALSE
